| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |